ID: ALA4637077

Max Phase: Preclinical

Molecular Formula: C6H5NOS2

Molecular Weight: 171.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc2cnsc2s1

Standard InChI:  InChI=1S/C6H5NOS2/c1-8-5-2-4-3-7-10-6(4)9-5/h2-3H,1H3

Standard InChI Key:  FQHSOLRPCSGPAQ-UHFFFAOYSA-N

Associated Targets(Human)

Exportin-1 375 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 171.25Molecular Weight (Monoisotopic): 170.9813AlogP: 2.37#Rotatable Bonds: 1
Polar Surface Area: 22.12Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.85CX LogP: 2.18CX LogD: 2.18
Aromatic Rings: 2Heavy Atoms: 10QED Weighted: 0.66Np Likeness Score: -0.56

References

1. Shaikhqasem A, Dickmanns A, Neumann P, Ficner R..  (2020)  Characterization of Inhibition Reveals Distinctive Properties for Human and Saccharomyces cerevisiae CRM1.,  63  (14): [PMID:32585100] [10.1021/acs.jmedchem.0c00143]

Source